Statistics for Recommendations for standardized pathological characterization of residual disease for neoadjuvant clinical trials of breast cancer by the BIG-NABCG collaboration
Total visits
| views | |
|---|---|
| Recommendations for standardized pathological characterization of residual disease for neoadjuvant clinical trials of breast cancer by the BIG-NABCG collaboration | 291 |
Total visits per month
| views | |
|---|---|
| May 2024 | 0 |
| June 2024 | 0 |
| July 2024 | 0 |
| August 2024 | 0 |
| September 2024 | 0 |
| October 2024 | 0 |
| November 2024 | 0 |
Top country views
| views | |
|---|---|
| United States | 210 |
| Germany | 17 |
| China | 6 |
| Russia | 6 |
| Ukraine | 6 |
| United Kingdom | 4 |
| Sweden | 4 |
| Netherlands | 3 |
| Canada | 2 |
| Belarus | 1 |
| Switzerland | 1 |
| Guinea | 1 |
| India | 1 |
| Japan | 1 |
| Malaysia | 1 |
| Pakistan | 1 |
| Serbia | 1 |
Top city views
| views | |
|---|---|
| Wilmington | 48 |
| Fairfield | 30 |
| Ann Arbor | 24 |
| Kiez | 15 |
| Houston | 11 |
| Cambridge | 10 |
| San Francisco | 8 |
| White Plains | 8 |
| Jacksonville | 7 |
| Kiev | 6 |
| Indianapolis | 4 |
| Lake Mary | 4 |
| Shenzhen | 4 |
| Stockholm | 4 |
| Maasdijk | 3 |
| Saint Petersburg | 3 |
| Warrington | 3 |
| Brooklyn | 2 |
| Concord | 2 |
| Gunzenhausen | 2 |
| Toronto | 2 |
| Washington | 2 |
| Ashburn | 1 |
| Baltimore | 1 |
| Beijing | 1 |
| Belgrade | 1 |
| Bloomsbury | 1 |
| Chicago | 1 |
| Cointrin | 1 |
| Islamabad | 1 |
| Minsk | 1 |
| Moscow | 1 |
| Mountain View | 1 |
| Mumbai | 1 |
| Norwalk | 1 |
| Overland Park | 1 |
| Philadelphia | 1 |
| Ryazan | 1 |
| Seremban | 1 |
| Zheleznogorsk | 1 |